No Photo Available

Last Update

2016-12-12T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Kathleen Dungan?

Dr. Kathleen M. Dungan

Division of Endocrinology, Diabetes and Metabolism

The Ohio State University Medical Center

Direct Phone: (614) ***-****       

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

The Ohio State University Medical Center

660 Ackerman Road

Columbus, Ohio 43218

United States

Company Description

Located in Columbus, Ohio, The Ohio State University Medical Center is one of the largest and most diverse academic medical centers in the country and the only academic medical center in central Ohio. Driven by our mission to improve people's lives thro ... more

Find other employees at this company (7,646)

Background Information

Employment History

Associate Professor, Associate Division Director for Clinical Services, Division of Endocrinology, Diabetes and Metabolism

The Ohio State University

Central Ohio Community Leadership Board President

American Diabetes Association

Editor

Endotext

Program Director

eDiabetes Review

Consultant

GlaxoSmithKline plc

Endocrinologist, Division of Endocrinology, Diabetes, and Metabolism

The Ohio State University School of Medicine

Affiliations

Division CME Committee
Endocrine Society Clinical Endocrine Update

Fellow In the Division of Endocrinology, Department of Medicine
University of North Carolina School of Medicine

Education

OSU

MD

MD

University of Rochester

MPH

Web References (34 Total References)


"For patients who cannot tolerate or ...

www.newswire.ca [cached]

"For patients who cannot tolerate or have contraindications to metformin, a sulfonylurea is often prescribed as first-line therapy for type 2 diabetes," said Kathleen Dungan, M.D., endocrinologist, associate professor, The Ohio State University Wexner Medical Center, and lead study author.


"For patients who cannot tolerate or ...

www.biospace.com [cached]

"For patients who cannot tolerate or have contraindications to metformin, a sulfonylurea is often prescribed as first-line therapy for type 2 diabetes," said Kathleen Dungan, M.D., endocrinologist, associate professor, The Ohio State University Wexner Medical Center, and lead study author.

...
1 Dungan, K, Weitgasser R, Manghi FP, et. al. Efficacy and Safety of Once Weekly Dulaglutide Added on to Sulfonylurea in Type 2 Diabetes (AWARD-8). Abstract 0219-PD. Presented at 2015 International Diabetes Federation (IDF) World Congress; 30 November 4 December, Vancouver, Canada.


"Diabetes is a progressive disease that ...

www.stockhouse.com [cached]

"Diabetes is a progressive disease that affects every patient differently," said Kathleen Dungan, MD, endocrinologist, associate professor, The Ohio State University Wexner Medical Center.

...
Dungan, K, Povedano, S, et al. Efficacy and Safety of Once Weekly Dulaglutide versus Once Daily Liraglutide in Type 2 Diabetes (AWARD-6). Abstract 110-LB. Presented at 74th American Diabetes Association (ADA) Scientific Sessions; June 13-17, 2014; San Francisco, CA. International Diabetes Federation. IDF Diabetes Atlas, 6th edn.Brussels, Belgium: International Diabetes Federation, 2013. http://www.idf.org/diabetesatlas.


The best Clinical Endocrinology source in the world. - Endotext

www.endotext.org [cached]

Diabetes Mellitus and Carbohydrate Metabolism---DiabetesManagerEditor: Kathleen Dungan, MD, MPH


Editorial Team - Endotext

www.endotext.org [cached]

Kathleen Dungan

...
Kathleen Dungan
Associate Professor of Medicine at The Ohio State University Division of Endocrinology, Diabetes and Metabolism. Dr. Dungan attended medical school at OSU and completed her residency and fellowship in 2006 at University of North Carolina. She then returned to OSU where she serves as the division Associate Director of Clinical Services and the director of endocrine clinical trials, and oversees the inpatient diabetes program. She divides her time in clinical care and research in diabetes. Her research focuses on diabetes clinical trials, and ranges from quality improvement, pharmaceutical, and device interventions in the inpatient and outpatient settings. She has presented several times at national meetings such as the ADA and Endocrine Society and has published numerous manuscripts and chapters ranging from glucose monitoring, incretin based therapies, and insulins, to mechanistic and outcomes studies in hospitalized patients. She serves on the editorial board of Diabetes Technology & Therapeutics. She serves as the American Diabetes Association Central Ohio Community Leadership Board president and on the national ADA Scientific Sessions planning committee.
...
Kathleen Dungan

Similar Profiles

Other People with this Name

Other people with the name Dungan

C. Dungan
Hogan Lovells LLP

Drew Dungan
Derse Exhibits

Susan Dungan
Mount Franklin Foods , LLC

Robin Dungan
Pyramid Incorporated

David Dungan
The Hackett Group Inc

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory